Sheel Biotech IPO is a SME issue open from 30 September – 3 October.
₹15
Implied listing gain: 23.80%
15.92x
Times the issue was bid for
On the GMP figure: grey market premium is quoted by informal dealers. No exchange publishes it, no regulator oversees it, and it is not a forecast of the listing price. Issues quoting a strong premium have listed below their issue price. Weigh the financials and the risk factors in the RHP well above this number.
Our reading of the numbers below — growth rates, margins, pricing and demand are calculated from the company's own filed figures, not copied from anywhere.
Funds blocked after close
~5 days
from the closing date to listing
Total subscription
15.92x
across all categories
For Sheel Biotech, bidding runs 30-3 October, allotment is finalised on 6 oct 2025, the shares list on 8 oct 2025. Applications that do not receive an allotment have their UPI mandate released around 3 days after the issue closes. Counting from the close of bidding, money stays blocked for roughly 5 days before listing decides what the holding is worth.
The book is 15.92x subscribed across all categories. That headline covers institutional, non-institutional and retail bids together, and allotment odds are decided within each category separately — an issue can be heavily subscribed overall while the retail portion is comfortable, or the other way round. An oversubscribed retail book is settled by a draw on single-lot applications, so more distinct PANs help where a bigger single bid does not.
Skyline Financial Services Pvt. Ltd. is the registrar for this issue, which means the allotment status for Sheel Biotech is published on their portal from 6 oct 2025. A PAN, application number or demat client ID is enough to look it up; the credited shares also appear in the demat account itself a day or so before listing.
The figures above are worked out from the issue's own filed numbers and are for information only. They are not investment advice — read the RHP before you apply.
| IPO Date | 30 September – 3 October |
| Face Value | 10 Per Share |
| Price Range | |
| Issue Size | |
| Lot Size | Shares |
| Allotment Date | 6 oct 2025 |
| Listing Date | 8 oct 2025 |
| Registrar | Skyline Financial Services Pvt. Ltd. |
| Category | Allocation |
|---|---|
| Retail Investors | |
| QIB (Qualified Institutional Buyers) | |
| HNI (High Net Worth Individuals) |
Sheel Biotech IPO is a SME issue open from 30 September – 3 October.
The issue is open 30 September – 3 October. Bids must be placed, and any UPI mandate approved, before the cut-off on the closing day.
Basis of allotment is expected to be finalised on 6 oct 2025. You can check your status on the registrar's website (Skyline Financial Services Pvt. Ltd.) using your PAN.
Listing is expected on 8 oct 2025, following the T+3 timeline that applies to Indian IPOs.
This information is for educational purposes only. Please conduct your own research and consult with financial advisors before making investment decisions. IPO investments carry market risks.
Or see the full upcoming IPO list, today's grey market premium, subscription figures and allotment status.

HDFC Bank ke Chairman Atanu Chakraborty ne 18 March 2026 ko "values aur ethics" ka hawala dete hue istifa de diya. Stock 9% crash hua, ₹61,000 crore market cap ek jhatke mein gaya. Jaaniye poori kahani aur aapko kya karna chahiye.

Reliance Jio IPO 2026 mein India ka sabse bada IPO ban sakta hai — $180 billion valuation, $4.3 billion fundraise. Lekin abhi ek regulatory roadblock aaya hai. Jaaniye poori detail — date, price, GMP, aur kya aapko invest karna chahiye.

US-Iran War ke baad se India mein crude oil $100 par, rupee record low ₹92 par, FPI ne ₹52,704 crore nikale, aur LPG sankat gahrata ja raha hai. Janiye is poori situation ka aapke investments par kya asar padega.